Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracaine eye drops as preemptive topical anesthesia for botulinum toxin injections in blepharospasm
TCTR20230530007Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tetracaine in idiopathic blepharospasm (BEB), sponsored by Chulalongkorn University. Started Nov 2023; status: completed.
02
Drugs
tetracaine
03
Conditions
idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on TCTR20230530007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230530007.